nodes	percent_of_prediction	percent_of_DWPC	metapath
Pravastatin—ABCG2—Vandetanib—thyroid cancer	0.129	0.173	CbGbCtD
Pravastatin—ABCB11—Doxorubicin—thyroid cancer	0.0993	0.133	CbGbCtD
Pravastatin—ABCC2—Sorafenib—thyroid cancer	0.0861	0.115	CbGbCtD
Pravastatin—ABCG2—Sorafenib—thyroid cancer	0.0778	0.104	CbGbCtD
Pravastatin—ABCC2—Doxorubicin—thyroid cancer	0.0522	0.0698	CbGbCtD
Pravastatin—ABCG2—Doxorubicin—thyroid cancer	0.0472	0.0631	CbGbCtD
Pravastatin—CYP3A5—Sorafenib—thyroid cancer	0.0431	0.0577	CbGbCtD
Pravastatin—CYP2C8—Sorafenib—thyroid cancer	0.0414	0.0554	CbGbCtD
Pravastatin—CYP2C9—Sorafenib—thyroid cancer	0.0289	0.0387	CbGbCtD
Pravastatin—ABCB1—Sorafenib—thyroid cancer	0.0281	0.0375	CbGbCtD
Pravastatin—CYP3A4—Vandetanib—thyroid cancer	0.0279	0.0373	CbGbCtD
Pravastatin—CYP2D6—Sorafenib—thyroid cancer	0.0264	0.0354	CbGbCtD
Pravastatin—ABCB1—Doxorubicin—thyroid cancer	0.017	0.0228	CbGbCtD
Pravastatin—CYP3A4—Sorafenib—thyroid cancer	0.0168	0.0225	CbGbCtD
Pravastatin—CYP2D6—Doxorubicin—thyroid cancer	0.016	0.0215	CbGbCtD
Pravastatin—CYP3A4—Doxorubicin—thyroid cancer	0.0102	0.0136	CbGbCtD
Pravastatin—Arrhythmia—Sorafenib—thyroid cancer	0.000764	0.00404	CcSEcCtD
Pravastatin—Alopecia—Sorafenib—thyroid cancer	0.000755	0.004	CcSEcCtD
Pravastatin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000736	0.0039	CcSEcCtD
Pravastatin—Dysgeusia—Sorafenib—thyroid cancer	0.000729	0.00386	CcSEcCtD
Pravastatin—Jaundice cholestatic—Epirubicin—thyroid cancer	0.000716	0.00379	CcSEcCtD
Pravastatin—Muscle spasms—Sorafenib—thyroid cancer	0.000716	0.00379	CcSEcCtD
Pravastatin—Abdominal pain—Vandetanib—thyroid cancer	0.000712	0.00377	CcSEcCtD
Pravastatin—Body temperature increased—Vandetanib—thyroid cancer	0.000712	0.00377	CcSEcCtD
Pravastatin—Viral infection—Epirubicin—thyroid cancer	0.000697	0.00369	CcSEcCtD
Pravastatin—Anaemia—Sorafenib—thyroid cancer	0.000688	0.00364	CcSEcCtD
Pravastatin—Angioedema—Sorafenib—thyroid cancer	0.00068	0.0036	CcSEcCtD
Pravastatin—Nocturia—Epirubicin—thyroid cancer	0.000678	0.00359	CcSEcCtD
Pravastatin—Leukopenia—Sorafenib—thyroid cancer	0.000666	0.00352	CcSEcCtD
Pravastatin—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.000663	0.00351	CcSEcCtD
Pravastatin—Cough—Sorafenib—thyroid cancer	0.000649	0.00344	CcSEcCtD
Pravastatin—Asthenia—Vandetanib—thyroid cancer	0.000646	0.00342	CcSEcCtD
Pravastatin—Viral infection—Doxorubicin—thyroid cancer	0.000645	0.00341	CcSEcCtD
Pravastatin—Hypertension—Sorafenib—thyroid cancer	0.000643	0.0034	CcSEcCtD
Pravastatin—Pruritus—Vandetanib—thyroid cancer	0.000637	0.00337	CcSEcCtD
Pravastatin—Musculoskeletal pain—Epirubicin—thyroid cancer	0.000637	0.00337	CcSEcCtD
Pravastatin—Arthralgia—Sorafenib—thyroid cancer	0.000634	0.00335	CcSEcCtD
Pravastatin—Myalgia—Sorafenib—thyroid cancer	0.000634	0.00335	CcSEcCtD
Pravastatin—Hepatocellular injury—Epirubicin—thyroid cancer	0.000629	0.00333	CcSEcCtD
Pravastatin—Phosphatase alkaline increased—Epirubicin—thyroid cancer	0.000629	0.00333	CcSEcCtD
Pravastatin—Nocturia—Doxorubicin—thyroid cancer	0.000628	0.00332	CcSEcCtD
Pravastatin—Diarrhoea—Vandetanib—thyroid cancer	0.000616	0.00326	CcSEcCtD
Pravastatin—Anaphylactic shock—Sorafenib—thyroid cancer	0.000607	0.00321	CcSEcCtD
Pravastatin—Infection—Sorafenib—thyroid cancer	0.000603	0.00319	CcSEcCtD
Pravastatin—Dizziness—Vandetanib—thyroid cancer	0.000595	0.00315	CcSEcCtD
Pravastatin—Thrombocytopenia—Sorafenib—thyroid cancer	0.000595	0.00315	CcSEcCtD
Pravastatin—Neuropathy—Epirubicin—thyroid cancer	0.000591	0.00313	CcSEcCtD
Pravastatin—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.000589	0.00312	CcSEcCtD
Pravastatin—Hepatocellular injury—Doxorubicin—thyroid cancer	0.000582	0.00308	CcSEcCtD
Pravastatin—Phosphatase alkaline increased—Doxorubicin—thyroid cancer	0.000582	0.00308	CcSEcCtD
Pravastatin—Anorexia—Sorafenib—thyroid cancer	0.000579	0.00306	CcSEcCtD
Pravastatin—Vomiting—Vandetanib—thyroid cancer	0.000572	0.00303	CcSEcCtD
Pravastatin—Rash—Vandetanib—thyroid cancer	0.000568	0.003	CcSEcCtD
Pravastatin—Dermatitis—Vandetanib—thyroid cancer	0.000567	0.003	CcSEcCtD
Pravastatin—Headache—Vandetanib—thyroid cancer	0.000564	0.00298	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000553	0.00293	CcSEcCtD
Pravastatin—Neuropathy—Doxorubicin—thyroid cancer	0.000547	0.00289	CcSEcCtD
Pravastatin—Dyspnoea—Sorafenib—thyroid cancer	0.000541	0.00287	CcSEcCtD
Pravastatin—Nausea—Vandetanib—thyroid cancer	0.000535	0.00283	CcSEcCtD
Pravastatin—Dyspepsia—Sorafenib—thyroid cancer	0.000535	0.00283	CcSEcCtD
Pravastatin—Decreased appetite—Sorafenib—thyroid cancer	0.000528	0.00279	CcSEcCtD
Pravastatin—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.000525	0.00278	CcSEcCtD
Pravastatin—Fatigue—Sorafenib—thyroid cancer	0.000524	0.00277	CcSEcCtD
Pravastatin—Hepatic function abnormal—Epirubicin—thyroid cancer	0.000523	0.00276	CcSEcCtD
Pravastatin—Photosensitivity—Epirubicin—thyroid cancer	0.00052	0.00275	CcSEcCtD
Pravastatin—Pain—Sorafenib—thyroid cancer	0.000519	0.00275	CcSEcCtD
Pravastatin—Constipation—Sorafenib—thyroid cancer	0.000519	0.00275	CcSEcCtD
Pravastatin—Vascular purpura—Epirubicin—thyroid cancer	0.000511	0.0027	CcSEcCtD
Pravastatin—Hepatic failure—Epirubicin—thyroid cancer	0.000508	0.00269	CcSEcCtD
Pravastatin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000497	0.00263	CcSEcCtD
Pravastatin—Renal failure acute—Epirubicin—thyroid cancer	0.000495	0.00262	CcSEcCtD
Pravastatin—Hot flush—Epirubicin—thyroid cancer	0.000488	0.00258	CcSEcCtD
Pravastatin—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.000486	0.00257	CcSEcCtD
Pravastatin—Menopausal symptoms—Epirubicin—thyroid cancer	0.000484	0.00256	CcSEcCtD
Pravastatin—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000484	0.00256	CcSEcCtD
Pravastatin—Urticaria—Sorafenib—thyroid cancer	0.000483	0.00255	CcSEcCtD
Pravastatin—Photosensitivity—Doxorubicin—thyroid cancer	0.000481	0.00255	CcSEcCtD
Pravastatin—Body temperature increased—Sorafenib—thyroid cancer	0.00048	0.00254	CcSEcCtD
Pravastatin—Abdominal pain—Sorafenib—thyroid cancer	0.00048	0.00254	CcSEcCtD
Pravastatin—Purpura—Epirubicin—thyroid cancer	0.000474	0.00251	CcSEcCtD
Pravastatin—Vascular purpura—Doxorubicin—thyroid cancer	0.000472	0.0025	CcSEcCtD
Pravastatin—Hepatic failure—Doxorubicin—thyroid cancer	0.00047	0.00249	CcSEcCtD
Pravastatin—Renal failure acute—Doxorubicin—thyroid cancer	0.000458	0.00242	CcSEcCtD
Pravastatin—Diplopia—Epirubicin—thyroid cancer	0.000457	0.00242	CcSEcCtD
Pravastatin—Hot flush—Doxorubicin—thyroid cancer	0.000452	0.00239	CcSEcCtD
Pravastatin—Affect lability—Epirubicin—thyroid cancer	0.00045	0.00238	CcSEcCtD
Pravastatin—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000448	0.00237	CcSEcCtD
Pravastatin—Hypersensitivity—Sorafenib—thyroid cancer	0.000447	0.00237	CcSEcCtD
Pravastatin—Purpura—Doxorubicin—thyroid cancer	0.000438	0.00232	CcSEcCtD
Pravastatin—Asthenia—Sorafenib—thyroid cancer	0.000436	0.00231	CcSEcCtD
Pravastatin—Mood swings—Epirubicin—thyroid cancer	0.000433	0.00229	CcSEcCtD
Pravastatin—Pruritus—Sorafenib—thyroid cancer	0.00043	0.00227	CcSEcCtD
Pravastatin—Diplopia—Doxorubicin—thyroid cancer	0.000423	0.00224	CcSEcCtD
Pravastatin—Liver function test abnormal—Epirubicin—thyroid cancer	0.000422	0.00223	CcSEcCtD
Pravastatin—Dry skin—Epirubicin—thyroid cancer	0.000419	0.00221	CcSEcCtD
Pravastatin—Affect lability—Doxorubicin—thyroid cancer	0.000416	0.0022	CcSEcCtD
Pravastatin—Diarrhoea—Sorafenib—thyroid cancer	0.000416	0.0022	CcSEcCtD
Pravastatin—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000411	0.00218	CcSEcCtD
Pravastatin—Nasopharyngitis—Epirubicin—thyroid cancer	0.000408	0.00216	CcSEcCtD
Pravastatin—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000403	0.00213	CcSEcCtD
Pravastatin—Muscular weakness—Epirubicin—thyroid cancer	0.000403	0.00213	CcSEcCtD
Pravastatin—Dizziness—Sorafenib—thyroid cancer	0.000402	0.00213	CcSEcCtD
Pravastatin—Mood swings—Doxorubicin—thyroid cancer	0.0004	0.00212	CcSEcCtD
Pravastatin—Abdominal distension—Epirubicin—thyroid cancer	0.000397	0.0021	CcSEcCtD
Pravastatin—Influenza—Epirubicin—thyroid cancer	0.000395	0.00209	CcSEcCtD
Pravastatin—Eosinophilia—Epirubicin—thyroid cancer	0.000391	0.00207	CcSEcCtD
Pravastatin—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00039	0.00206	CcSEcCtD
Pravastatin—Dry skin—Doxorubicin—thyroid cancer	0.000387	0.00205	CcSEcCtD
Pravastatin—Pancreatitis—Epirubicin—thyroid cancer	0.000387	0.00205	CcSEcCtD
Pravastatin—Vomiting—Sorafenib—thyroid cancer	0.000386	0.00204	CcSEcCtD
Pravastatin—Angina pectoris—Epirubicin—thyroid cancer	0.000385	0.00203	CcSEcCtD
Pravastatin—Rash—Sorafenib—thyroid cancer	0.000383	0.00203	CcSEcCtD
Pravastatin—Dermatitis—Sorafenib—thyroid cancer	0.000383	0.00202	CcSEcCtD
Pravastatin—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000381	0.00201	CcSEcCtD
Pravastatin—Headache—Sorafenib—thyroid cancer	0.000381	0.00201	CcSEcCtD
Pravastatin—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000378	0.002	CcSEcCtD
Pravastatin—Muscular weakness—Doxorubicin—thyroid cancer	0.000373	0.00197	CcSEcCtD
Pravastatin—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000373	0.00197	CcSEcCtD
Pravastatin—Dysuria—Epirubicin—thyroid cancer	0.000369	0.00195	CcSEcCtD
Pravastatin—Abdominal distension—Doxorubicin—thyroid cancer	0.000368	0.00195	CcSEcCtD
Pravastatin—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000367	0.00194	CcSEcCtD
Pravastatin—Influenza—Doxorubicin—thyroid cancer	0.000365	0.00193	CcSEcCtD
Pravastatin—Eosinophilia—Doxorubicin—thyroid cancer	0.000362	0.00191	CcSEcCtD
Pravastatin—Nausea—Sorafenib—thyroid cancer	0.000361	0.00191	CcSEcCtD
Pravastatin—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00036	0.00191	CcSEcCtD
Pravastatin—Weight increased—Epirubicin—thyroid cancer	0.000359	0.0019	CcSEcCtD
Pravastatin—Pancreatitis—Doxorubicin—thyroid cancer	0.000358	0.00189	CcSEcCtD
Pravastatin—Weight decreased—Epirubicin—thyroid cancer	0.000357	0.00189	CcSEcCtD
Pravastatin—Angina pectoris—Doxorubicin—thyroid cancer	0.000356	0.00188	CcSEcCtD
Pravastatin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000349	0.00185	CcSEcCtD
Pravastatin—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000345	0.00183	CcSEcCtD
Pravastatin—Jaundice—Epirubicin—thyroid cancer	0.000343	0.00182	CcSEcCtD
Pravastatin—Urinary tract infection—Epirubicin—thyroid cancer	0.000342	0.00181	CcSEcCtD
Pravastatin—Dysuria—Doxorubicin—thyroid cancer	0.000342	0.00181	CcSEcCtD
Pravastatin—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000339	0.0018	CcSEcCtD
Pravastatin—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000333	0.00176	CcSEcCtD
Pravastatin—Weight increased—Doxorubicin—thyroid cancer	0.000332	0.00176	CcSEcCtD
Pravastatin—Weight decreased—Doxorubicin—thyroid cancer	0.00033	0.00175	CcSEcCtD
Pravastatin—Sinusitis—Epirubicin—thyroid cancer	0.00033	0.00175	CcSEcCtD
Pravastatin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000323	0.00171	CcSEcCtD
Pravastatin—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000319	0.00169	CcSEcCtD
Pravastatin—Jaundice—Doxorubicin—thyroid cancer	0.000317	0.00168	CcSEcCtD
Pravastatin—Rhinitis—Epirubicin—thyroid cancer	0.000317	0.00168	CcSEcCtD
Pravastatin—Urinary tract infection—Doxorubicin—thyroid cancer	0.000317	0.00167	CcSEcCtD
Pravastatin—Hepatitis—Epirubicin—thyroid cancer	0.000316	0.00167	CcSEcCtD
Pravastatin—Hypoaesthesia—Epirubicin—thyroid cancer	0.000314	0.00166	CcSEcCtD
Pravastatin—Pharyngitis—Epirubicin—thyroid cancer	0.000314	0.00166	CcSEcCtD
Pravastatin—Sinusitis—Doxorubicin—thyroid cancer	0.000306	0.00162	CcSEcCtD
Pravastatin—Visual impairment—Epirubicin—thyroid cancer	0.000304	0.00161	CcSEcCtD
Pravastatin—Erythema multiforme—Epirubicin—thyroid cancer	0.000299	0.00158	CcSEcCtD
Pravastatin—Tinnitus—Epirubicin—thyroid cancer	0.000295	0.00156	CcSEcCtD
Pravastatin—Flushing—Epirubicin—thyroid cancer	0.000293	0.00155	CcSEcCtD
Pravastatin—Cardiac disorder—Epirubicin—thyroid cancer	0.000293	0.00155	CcSEcCtD
Pravastatin—Rhinitis—Doxorubicin—thyroid cancer	0.000293	0.00155	CcSEcCtD
Pravastatin—Hepatitis—Doxorubicin—thyroid cancer	0.000292	0.00155	CcSEcCtD
Pravastatin—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000291	0.00154	CcSEcCtD
Pravastatin—Pharyngitis—Doxorubicin—thyroid cancer	0.00029	0.00154	CcSEcCtD
Pravastatin—Chills—Epirubicin—thyroid cancer	0.000283	0.0015	CcSEcCtD
Pravastatin—Arrhythmia—Epirubicin—thyroid cancer	0.000282	0.00149	CcSEcCtD
Pravastatin—Visual impairment—Doxorubicin—thyroid cancer	0.000282	0.00149	CcSEcCtD
Pravastatin—Alopecia—Epirubicin—thyroid cancer	0.000279	0.00148	CcSEcCtD
Pravastatin—Erythema multiforme—Doxorubicin—thyroid cancer	0.000276	0.00146	CcSEcCtD
Pravastatin—Tinnitus—Doxorubicin—thyroid cancer	0.000273	0.00144	CcSEcCtD
Pravastatin—Flushing—Doxorubicin—thyroid cancer	0.000271	0.00144	CcSEcCtD
Pravastatin—Cardiac disorder—Doxorubicin—thyroid cancer	0.000271	0.00144	CcSEcCtD
Pravastatin—Flatulence—Epirubicin—thyroid cancer	0.000271	0.00143	CcSEcCtD
Pravastatin—Tension—Epirubicin—thyroid cancer	0.00027	0.00143	CcSEcCtD
Pravastatin—Dysgeusia—Epirubicin—thyroid cancer	0.000269	0.00143	CcSEcCtD
Pravastatin—Nervousness—Epirubicin—thyroid cancer	0.000267	0.00141	CcSEcCtD
Pravastatin—Muscle spasms—Epirubicin—thyroid cancer	0.000264	0.0014	CcSEcCtD
Pravastatin—Chills—Doxorubicin—thyroid cancer	0.000262	0.00139	CcSEcCtD
Pravastatin—Arrhythmia—Doxorubicin—thyroid cancer	0.000261	0.00138	CcSEcCtD
Pravastatin—Vision blurred—Epirubicin—thyroid cancer	0.000259	0.00137	CcSEcCtD
Pravastatin—Alopecia—Doxorubicin—thyroid cancer	0.000258	0.00137	CcSEcCtD
Pravastatin—Ill-defined disorder—Epirubicin—thyroid cancer	0.000255	0.00135	CcSEcCtD
Pravastatin—Anaemia—Epirubicin—thyroid cancer	0.000254	0.00135	CcSEcCtD
Pravastatin—Flatulence—Doxorubicin—thyroid cancer	0.000251	0.00133	CcSEcCtD
Pravastatin—Tension—Doxorubicin—thyroid cancer	0.00025	0.00132	CcSEcCtD
Pravastatin—Dysgeusia—Doxorubicin—thyroid cancer	0.000249	0.00132	CcSEcCtD
Pravastatin—Malaise—Epirubicin—thyroid cancer	0.000248	0.00131	CcSEcCtD
Pravastatin—Nervousness—Doxorubicin—thyroid cancer	0.000247	0.00131	CcSEcCtD
Pravastatin—Vertigo—Epirubicin—thyroid cancer	0.000247	0.00131	CcSEcCtD
Pravastatin—Leukopenia—Epirubicin—thyroid cancer	0.000246	0.0013	CcSEcCtD
Pravastatin—Muscle spasms—Doxorubicin—thyroid cancer	0.000245	0.00129	CcSEcCtD
Pravastatin—Cough—Epirubicin—thyroid cancer	0.00024	0.00127	CcSEcCtD
Pravastatin—Vision blurred—Doxorubicin—thyroid cancer	0.00024	0.00127	CcSEcCtD
Pravastatin—Hypertension—Epirubicin—thyroid cancer	0.000237	0.00126	CcSEcCtD
Pravastatin—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000236	0.00125	CcSEcCtD
Pravastatin—Anaemia—Doxorubicin—thyroid cancer	0.000235	0.00124	CcSEcCtD
Pravastatin—Arthralgia—Epirubicin—thyroid cancer	0.000234	0.00124	CcSEcCtD
Pravastatin—Chest pain—Epirubicin—thyroid cancer	0.000234	0.00124	CcSEcCtD
Pravastatin—Myalgia—Epirubicin—thyroid cancer	0.000234	0.00124	CcSEcCtD
Pravastatin—Anxiety—Epirubicin—thyroid cancer	0.000233	0.00123	CcSEcCtD
Pravastatin—Discomfort—Epirubicin—thyroid cancer	0.000231	0.00122	CcSEcCtD
Pravastatin—Malaise—Doxorubicin—thyroid cancer	0.000229	0.00121	CcSEcCtD
Pravastatin—Vertigo—Doxorubicin—thyroid cancer	0.000229	0.00121	CcSEcCtD
Pravastatin—Leukopenia—Doxorubicin—thyroid cancer	0.000228	0.00121	CcSEcCtD
Pravastatin—Confusional state—Epirubicin—thyroid cancer	0.000226	0.0012	CcSEcCtD
Pravastatin—Oedema—Epirubicin—thyroid cancer	0.000224	0.00119	CcSEcCtD
Pravastatin—Anaphylactic shock—Epirubicin—thyroid cancer	0.000224	0.00119	CcSEcCtD
Pravastatin—Infection—Epirubicin—thyroid cancer	0.000223	0.00118	CcSEcCtD
Pravastatin—Cough—Doxorubicin—thyroid cancer	0.000222	0.00117	CcSEcCtD
Pravastatin—Thrombocytopenia—Epirubicin—thyroid cancer	0.00022	0.00116	CcSEcCtD
Pravastatin—Hypertension—Doxorubicin—thyroid cancer	0.00022	0.00116	CcSEcCtD
Pravastatin—Hyperhidrosis—Epirubicin—thyroid cancer	0.000217	0.00115	CcSEcCtD
Pravastatin—Arthralgia—Doxorubicin—thyroid cancer	0.000217	0.00115	CcSEcCtD
Pravastatin—Chest pain—Doxorubicin—thyroid cancer	0.000217	0.00115	CcSEcCtD
Pravastatin—Myalgia—Doxorubicin—thyroid cancer	0.000217	0.00115	CcSEcCtD
Pravastatin—Anxiety—Doxorubicin—thyroid cancer	0.000216	0.00114	CcSEcCtD
Pravastatin—Discomfort—Doxorubicin—thyroid cancer	0.000214	0.00113	CcSEcCtD
Pravastatin—Anorexia—Epirubicin—thyroid cancer	0.000214	0.00113	CcSEcCtD
Pravastatin—Confusional state—Doxorubicin—thyroid cancer	0.000209	0.00111	CcSEcCtD
Pravastatin—Oedema—Doxorubicin—thyroid cancer	0.000208	0.0011	CcSEcCtD
Pravastatin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000208	0.0011	CcSEcCtD
Pravastatin—Infection—Doxorubicin—thyroid cancer	0.000206	0.00109	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000205	0.00108	CcSEcCtD
Pravastatin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000203	0.00108	CcSEcCtD
Pravastatin—Insomnia—Epirubicin—thyroid cancer	0.000203	0.00107	CcSEcCtD
Pravastatin—Paraesthesia—Epirubicin—thyroid cancer	0.000202	0.00107	CcSEcCtD
Pravastatin—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000201	0.00106	CcSEcCtD
Pravastatin—Dyspnoea—Epirubicin—thyroid cancer	0.0002	0.00106	CcSEcCtD
Pravastatin—Anorexia—Doxorubicin—thyroid cancer	0.000198	0.00105	CcSEcCtD
Pravastatin—Dyspepsia—Epirubicin—thyroid cancer	0.000198	0.00105	CcSEcCtD
Pravastatin—Decreased appetite—Epirubicin—thyroid cancer	0.000195	0.00103	CcSEcCtD
Pravastatin—Fatigue—Epirubicin—thyroid cancer	0.000194	0.00102	CcSEcCtD
Pravastatin—Pain—Epirubicin—thyroid cancer	0.000192	0.00102	CcSEcCtD
Pravastatin—Constipation—Epirubicin—thyroid cancer	0.000192	0.00102	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000189	0.001	CcSEcCtD
Pravastatin—Insomnia—Doxorubicin—thyroid cancer	0.000188	0.000994	CcSEcCtD
Pravastatin—Paraesthesia—Doxorubicin—thyroid cancer	0.000186	0.000987	CcSEcCtD
Pravastatin—Dyspnoea—Doxorubicin—thyroid cancer	0.000185	0.00098	CcSEcCtD
Pravastatin—Feeling abnormal—Epirubicin—thyroid cancer	0.000185	0.000979	CcSEcCtD
Pravastatin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000184	0.000971	CcSEcCtD
Pravastatin—Dyspepsia—Doxorubicin—thyroid cancer	0.000183	0.000967	CcSEcCtD
Pravastatin—Decreased appetite—Doxorubicin—thyroid cancer	0.000181	0.000955	CcSEcCtD
Pravastatin—Fatigue—Doxorubicin—thyroid cancer	0.000179	0.000947	CcSEcCtD
Pravastatin—Urticaria—Epirubicin—thyroid cancer	0.000178	0.000944	CcSEcCtD
Pravastatin—Pain—Doxorubicin—thyroid cancer	0.000178	0.00094	CcSEcCtD
Pravastatin—Constipation—Doxorubicin—thyroid cancer	0.000178	0.00094	CcSEcCtD
Pravastatin—Abdominal pain—Epirubicin—thyroid cancer	0.000177	0.000939	CcSEcCtD
Pravastatin—Body temperature increased—Epirubicin—thyroid cancer	0.000177	0.000939	CcSEcCtD
Pravastatin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000171	0.000906	CcSEcCtD
Pravastatin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00017	0.000899	CcSEcCtD
Pravastatin—Hypersensitivity—Epirubicin—thyroid cancer	0.000165	0.000875	CcSEcCtD
Pravastatin—Urticaria—Doxorubicin—thyroid cancer	0.000165	0.000873	CcSEcCtD
Pravastatin—Abdominal pain—Doxorubicin—thyroid cancer	0.000164	0.000869	CcSEcCtD
Pravastatin—Body temperature increased—Doxorubicin—thyroid cancer	0.000164	0.000869	CcSEcCtD
Pravastatin—Asthenia—Epirubicin—thyroid cancer	0.000161	0.000852	CcSEcCtD
Pravastatin—Pruritus—Epirubicin—thyroid cancer	0.000159	0.00084	CcSEcCtD
Pravastatin—Diarrhoea—Epirubicin—thyroid cancer	0.000154	0.000813	CcSEcCtD
Pravastatin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000153	0.00081	CcSEcCtD
Pravastatin—Asthenia—Doxorubicin—thyroid cancer	0.000149	0.000788	CcSEcCtD
Pravastatin—Dizziness—Epirubicin—thyroid cancer	0.000148	0.000785	CcSEcCtD
Pravastatin—Pruritus—Doxorubicin—thyroid cancer	0.000147	0.000777	CcSEcCtD
Pravastatin—Vomiting—Epirubicin—thyroid cancer	0.000143	0.000755	CcSEcCtD
Pravastatin—Diarrhoea—Doxorubicin—thyroid cancer	0.000142	0.000752	CcSEcCtD
Pravastatin—Rash—Epirubicin—thyroid cancer	0.000142	0.000749	CcSEcCtD
Pravastatin—Dermatitis—Epirubicin—thyroid cancer	0.000141	0.000748	CcSEcCtD
Pravastatin—Headache—Epirubicin—thyroid cancer	0.000141	0.000744	CcSEcCtD
Pravastatin—Dizziness—Doxorubicin—thyroid cancer	0.000137	0.000727	CcSEcCtD
Pravastatin—Nausea—Epirubicin—thyroid cancer	0.000133	0.000705	CcSEcCtD
Pravastatin—Vomiting—Doxorubicin—thyroid cancer	0.000132	0.000699	CcSEcCtD
Pravastatin—Rash—Doxorubicin—thyroid cancer	0.000131	0.000693	CcSEcCtD
Pravastatin—Dermatitis—Doxorubicin—thyroid cancer	0.000131	0.000692	CcSEcCtD
Pravastatin—SLCO1B3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000131	0.00206	CbGpPWpGaD
Pravastatin—Headache—Doxorubicin—thyroid cancer	0.00013	0.000688	CcSEcCtD
Pravastatin—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000128	0.00203	CbGpPWpGaD
Pravastatin—SLCO2B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000127	0.00201	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—CHST14—thyroid cancer	0.000126	0.00199	CbGpPWpGaD
Pravastatin—Nausea—Doxorubicin—thyroid cancer	0.000123	0.000653	CcSEcCtD
Pravastatin—SLC16A1—Metabolism—HPGD—thyroid cancer	0.000123	0.00194	CbGpPWpGaD
Pravastatin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000123	0.00194	CbGpPWpGaD
Pravastatin—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000118	0.00186	CbGpPWpGaD
Pravastatin—SLC22A8—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000117	0.00185	CbGpPWpGaD
Pravastatin—SLC22A8—Transmembrane transport of small molecules—CP—thyroid cancer	0.000117	0.00185	CbGpPWpGaD
Pravastatin—SLC22A8—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000116	0.00182	CbGpPWpGaD
Pravastatin—SLC22A11—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000115	0.00182	CbGpPWpGaD
Pravastatin—SLC16A1—Cell surface interactions at the vascular wall—HRAS—thyroid cancer	0.000114	0.0018	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000114	0.0018	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—IFNA2—thyroid cancer	0.000114	0.00179	CbGpPWpGaD
Pravastatin—SLC16A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000113	0.00178	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—MINPP1—thyroid cancer	0.000113	0.00178	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—NDUFA13—thyroid cancer	0.000112	0.00177	CbGpPWpGaD
Pravastatin—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00011	0.00173	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.00011	0.00173	CbGpPWpGaD
Pravastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000109	0.00173	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—HPGD—thyroid cancer	0.000108	0.00171	CbGpPWpGaD
Pravastatin—SLCO2B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000107	0.00169	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—CHST14—thyroid cancer	0.000106	0.00166	CbGpPWpGaD
Pravastatin—SLC22A7—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000105	0.00165	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—MINPP1—thyroid cancer	0.000105	0.00165	CbGpPWpGaD
Pravastatin—SLCO1A2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000104	0.00164	CbGpPWpGaD
Pravastatin—SLCO1A2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000104	0.00164	CbGpPWpGaD
Pravastatin—SLCO1A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000103	0.00162	CbGpPWpGaD
Pravastatin—CYP3A5—Biological oxidations—RXRA—thyroid cancer	0.000102	0.00161	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—HPGD—thyroid cancer	0.000102	0.00161	CbGpPWpGaD
Pravastatin—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	9.94e-05	0.00157	CbGpPWpGaD
Pravastatin—SLC22A6—Transmembrane transport of small molecules—CP—thyroid cancer	9.8e-05	0.00155	CbGpPWpGaD
Pravastatin—SLC22A6—Transmembrane transport of small molecules—TPR—thyroid cancer	9.8e-05	0.00155	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—thyroid cancer	9.77e-05	0.00154	CbGpPWpGaD
Pravastatin—SLC22A11—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.69e-05	0.00153	CbGpPWpGaD
Pravastatin—SLC22A6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	9.64e-05	0.00152	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—NDUFA13—thyroid cancer	9.6e-05	0.00151	CbGpPWpGaD
Pravastatin—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	9.59e-05	0.00151	CbGpPWpGaD
Pravastatin—SLC16A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.5e-05	0.0015	CbGpPWpGaD
Pravastatin—ABCC2—Transmembrane transport of small molecules—TPR—thyroid cancer	9.5e-05	0.0015	CbGpPWpGaD
Pravastatin—ABCC2—Transmembrane transport of small molecules—CP—thyroid cancer	9.5e-05	0.0015	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	9.38e-05	0.00148	CbGpPWpGaD
Pravastatin—ABCC2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	9.34e-05	0.00147	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—CHST14—thyroid cancer	9.02e-05	0.00142	CbGpPWpGaD
Pravastatin—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	8.92e-05	0.00141	CbGpPWpGaD
Pravastatin—SLCO1B1—Transmembrane transport of small molecules—TPR—thyroid cancer	8.92e-05	0.00141	CbGpPWpGaD
Pravastatin—SLCO1B1—Transmembrane transport of small molecules—CP—thyroid cancer	8.92e-05	0.00141	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—NDUFA13—thyroid cancer	8.89e-05	0.0014	CbGpPWpGaD
Pravastatin—CYP2C8—Biological oxidations—RXRA—thyroid cancer	8.83e-05	0.00139	CbGpPWpGaD
Pravastatin—SLC22A8—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.79e-05	0.00139	CbGpPWpGaD
Pravastatin—SLC22A7—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.79e-05	0.00139	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	8.78e-05	0.00138	CbGpPWpGaD
Pravastatin—SLCO1B1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.77e-05	0.00138	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—HPGD—thyroid cancer	8.5e-05	0.00134	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—CHST14—thyroid cancer	8.35e-05	0.00132	CbGpPWpGaD
Pravastatin—SLCO1B3—Transmembrane transport of small molecules—RXRA—thyroid cancer	8.35e-05	0.00132	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	8.26e-05	0.0013	CbGpPWpGaD
Pravastatin—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	8.26e-05	0.0013	CbGpPWpGaD
Pravastatin—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	8.26e-05	0.0013	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	8.25e-05	0.0013	CbGpPWpGaD
Pravastatin—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.12e-05	0.00128	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—TPR—thyroid cancer	8.09e-05	0.00128	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—PRKAR1A—thyroid cancer	7.96e-05	0.00126	CbGpPWpGaD
Pravastatin—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.81e-05	0.00123	CbGpPWpGaD
Pravastatin—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	7.64e-05	0.0012	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	7.64e-05	0.0012	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—MINPP1—thyroid cancer	7.49e-05	0.00118	CbGpPWpGaD
Pravastatin—SLC22A8—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.39e-05	0.00116	CbGpPWpGaD
Pravastatin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.34e-05	0.00116	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—HPGD—thyroid cancer	7.27e-05	0.00115	CbGpPWpGaD
Pravastatin—CYP2D6—Biological oxidations—RXRA—thyroid cancer	7.25e-05	0.00114	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	7.22e-05	0.00114	CbGpPWpGaD
Pravastatin—CYP2C9—Biological oxidations—RXRA—thyroid cancer	7.18e-05	0.00113	CbGpPWpGaD
Pravastatin—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.11e-05	0.00112	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—TPR—thyroid cancer	7.07e-05	0.00112	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	7.07e-05	0.00112	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—PRKAR1A—thyroid cancer	6.96e-05	0.0011	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.9e-05	0.00109	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—HPGD—thyroid cancer	6.73e-05	0.00106	CbGpPWpGaD
Pravastatin—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.68e-05	0.00105	CbGpPWpGaD
Pravastatin—SLCO1A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.56e-05	0.00103	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—MINPP1—thyroid cancer	6.49e-05	0.00102	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—NDUFA13—thyroid cancer	6.37e-05	0.001	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—TPR—thyroid cancer	6.22e-05	0.00098	CbGpPWpGaD
Pravastatin—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.18e-05	0.000975	CbGpPWpGaD
Pravastatin—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.17e-05	0.000972	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—PRKAR1A—thyroid cancer	6.12e-05	0.000964	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—SLC5A5—thyroid cancer	6.06e-05	0.000955	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—CHST14—thyroid cancer	5.99e-05	0.000944	CbGpPWpGaD
Pravastatin—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.97e-05	0.000942	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.9e-05	0.00093	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—TPR—thyroid cancer	5.85e-05	0.000922	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—PRKAR1A—thyroid cancer	5.76e-05	0.000908	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.68e-05	0.000895	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—MINPP1—thyroid cancer	5.65e-05	0.000891	CbGpPWpGaD
Pravastatin—SLCO1B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.61e-05	0.000884	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.54e-05	0.000874	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—NDUFA13—thyroid cancer	5.51e-05	0.000869	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—MINPP1—thyroid cancer	5.32e-05	0.000839	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—SLC5A5—thyroid cancer	5.3e-05	0.000835	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—MINPP1—thyroid cancer	5.28e-05	0.000832	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	5.22e-05	0.000823	CbGpPWpGaD
Pravastatin—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.19e-05	0.000819	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—CHST14—thyroid cancer	5.18e-05	0.000817	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—RXRA—thyroid cancer	5.09e-05	0.000803	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.95e-05	0.000781	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—TPR—thyroid cancer	4.88e-05	0.00077	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—HPGD—thyroid cancer	4.82e-05	0.000761	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—PRKAR1A—thyroid cancer	4.81e-05	0.000758	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—NDUFA13—thyroid cancer	4.8e-05	0.000757	CbGpPWpGaD
Pravastatin—CYP3A4—Biological oxidations—RXRA—thyroid cancer	4.74e-05	0.000747	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—SLC5A5—thyroid cancer	4.65e-05	0.000734	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—NDUFA13—thyroid cancer	4.53e-05	0.000714	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—CHST14—thyroid cancer	4.52e-05	0.000712	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—NDUFA13—thyroid cancer	4.49e-05	0.000708	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	4.46e-05	0.000704	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	4.46e-05	0.000704	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—RXRA—thyroid cancer	4.45e-05	0.000701	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	4.39e-05	0.000693	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—SLC5A5—thyroid cancer	4.38e-05	0.000691	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.36e-05	0.000688	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.36e-05	0.000687	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—CHST14—thyroid cancer	4.26e-05	0.000671	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—NRAS—thyroid cancer	4.24e-05	0.000669	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—CHST14—thyroid cancer	4.22e-05	0.000665	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—HPGD—thyroid cancer	4.18e-05	0.000659	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—TPR—thyroid cancer	4.18e-05	0.000659	CbGpPWpGaD
Pravastatin—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	4.13e-05	0.000651	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	4.11e-05	0.000648	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	4.1e-05	0.000647	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—RXRA—thyroid cancer	3.91e-05	0.000616	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—TPR—thyroid cancer	3.87e-05	0.00061	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PRKAR1A—thyroid cancer	3.81e-05	0.0006	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.8e-05	0.0006	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.72e-05	0.000587	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—RXRA—thyroid cancer	3.68e-05	0.00058	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—SLC5A5—thyroid cancer	3.66e-05	0.000577	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—KRAS—thyroid cancer	3.65e-05	0.000575	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—HPGD—thyroid cancer	3.64e-05	0.000574	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.58e-05	0.000564	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	3.51e-05	0.000554	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—MINPP1—thyroid cancer	3.48e-05	0.000549	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—HPGD—thyroid cancer	3.43e-05	0.000541	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.43e-05	0.00054	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—HPGD—thyroid cancer	3.4e-05	0.000536	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.39e-05	0.000534	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.34e-05	0.000527	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—TP53—thyroid cancer	3.24e-05	0.000511	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—PPARG—thyroid cancer	3.21e-05	0.000507	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	3.17e-05	0.0005	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	3.13e-05	0.000493	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—HRAS—thyroid cancer	3.1e-05	0.000489	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—RXRA—thyroid cancer	3.07e-05	0.000484	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	3.06e-05	0.000483	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.99e-05	0.000471	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.96e-05	0.000467	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.93e-05	0.000462	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—SLC5A5—thyroid cancer	2.9e-05	0.000456	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—PPARG—thyroid cancer	2.81e-05	0.000443	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.81e-05	0.000443	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—CHST14—thyroid cancer	2.78e-05	0.000439	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—TPR—thyroid cancer	2.77e-05	0.000437	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.76e-05	0.000435	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—AKT1—thyroid cancer	2.74e-05	0.000432	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	2.73e-05	0.00043	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—RXRA—thyroid cancer	2.63e-05	0.000414	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.56e-05	0.000403	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—PTGS2—thyroid cancer	2.53e-05	0.000399	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—PPARG—thyroid cancer	2.47e-05	0.000389	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—RXRA—thyroid cancer	2.43e-05	0.000384	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—TPR—thyroid cancer	2.4e-05	0.000378	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	2.36e-05	0.000372	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.35e-05	0.000371	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—PPARG—thyroid cancer	2.32e-05	0.000366	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—HPGD—thyroid cancer	2.24e-05	0.000354	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—PTGS2—thyroid cancer	2.21e-05	0.000348	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—PTEN—thyroid cancer	2.2e-05	0.000348	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.14e-05	0.000337	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—TPR—thyroid cancer	2.09e-05	0.00033	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2.09e-05	0.00033	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—SLC5A5—thyroid cancer	2.07e-05	0.000327	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PRKAR1A—thyroid cancer	2.06e-05	0.000324	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—TPR—thyroid cancer	1.97e-05	0.000311	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—TPR—thyroid cancer	1.95e-05	0.000308	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—PTGS2—thyroid cancer	1.94e-05	0.000306	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—PPARG—thyroid cancer	1.94e-05	0.000306	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.94e-05	0.000306	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—PTEN—thyroid cancer	1.93e-05	0.000304	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.92e-05	0.000303	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—PTGS2—thyroid cancer	1.83e-05	0.000288	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.8e-05	0.000283	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.77e-05	0.000278	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—RXRA—thyroid cancer	1.74e-05	0.000275	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.74e-05	0.000275	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—PTEN—thyroid cancer	1.69e-05	0.000267	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.68e-05	0.000265	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—PPARG—thyroid cancer	1.66e-05	0.000262	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—PTEN—thyroid cancer	1.59e-05	0.000251	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.57e-05	0.000247	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PPARG—thyroid cancer	1.54e-05	0.000242	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—PTGS2—thyroid cancer	1.53e-05	0.000241	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—RXRA—thyroid cancer	1.51e-05	0.000238	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.48e-05	0.000233	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.47e-05	0.000232	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.46e-05	0.000231	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.37e-05	0.000216	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—PTEN—thyroid cancer	1.33e-05	0.00021	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—RXRA—thyroid cancer	1.32e-05	0.000207	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—PTGS2—thyroid cancer	1.3e-05	0.000206	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—TPR—thyroid cancer	1.29e-05	0.000203	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—AKT1—thyroid cancer	1.27e-05	0.0002	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.27e-05	0.0002	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—RXRA—thyroid cancer	1.24e-05	0.000195	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—RXRA—thyroid cancer	1.23e-05	0.000194	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PTGS2—thyroid cancer	1.21e-05	0.00019	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.2e-05	0.000188	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—PTEN—thyroid cancer	1.14e-05	0.000179	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—AKT1—thyroid cancer	1.11e-05	0.000175	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PPARG—thyroid cancer	1.1e-05	0.000174	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PTEN—thyroid cancer	1.05e-05	0.000166	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—AKT1—thyroid cancer	9.76e-06	0.000154	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—SLC5A5—thyroid cancer	9.64e-06	0.000152	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PPARG—thyroid cancer	9.53e-06	0.00015	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—AKT1—thyroid cancer	9.19e-06	0.000145	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PTGS2—thyroid cancer	8.66e-06	0.000136	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PPARG—thyroid cancer	8.3e-06	0.000131	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—RXRA—thyroid cancer	8.1e-06	0.000128	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PPARG—thyroid cancer	7.83e-06	0.000123	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PPARG—thyroid cancer	7.76e-06	0.000122	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—AKT1—thyroid cancer	7.67e-06	0.000121	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PTEN—thyroid cancer	7.55e-06	0.000119	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PTGS2—thyroid cancer	7.5e-06	0.000118	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—AKT1—thyroid cancer	6.56e-06	0.000103	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PTEN—thyroid cancer	6.54e-06	0.000103	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PTGS2—thyroid cancer	6.53e-06	0.000103	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PTGS2—thyroid cancer	6.16e-06	9.71e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PTGS2—thyroid cancer	6.1e-06	9.62e-05	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—AKT1—thyroid cancer	6.07e-06	9.57e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PTEN—thyroid cancer	5.7e-06	8.98e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PTEN—thyroid cancer	5.37e-06	8.46e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PTEN—thyroid cancer	5.32e-06	8.39e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PPARG—thyroid cancer	5.12e-06	8.07e-05	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—AKT1—thyroid cancer	4.35e-06	6.86e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PTGS2—thyroid cancer	4.02e-06	6.35e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—AKT1—thyroid cancer	3.77e-06	5.94e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PTEN—thyroid cancer	3.51e-06	5.53e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—AKT1—thyroid cancer	3.28e-06	5.18e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—AKT1—thyroid cancer	3.09e-06	4.88e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—AKT1—thyroid cancer	3.07e-06	4.84e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—AKT1—thyroid cancer	2.02e-06	3.19e-05	CbGpPWpGaD
